FDA Approved Levemir For Younger Kids

Jul. 5 | The U.S. Food and Drug Administration (FDA) approved Levemir® (insulin detemir [rDNA origin] injection) for use in children ages two to five years with type 1 diabetes. It is being marketed by Novo Nordisk, a world leader in diabetes care. With the expansion...

Diabetes Vaccine Trial Fails Step Two

Jun. 29 | A study report published by The Lancet on June 27, 2011 said that an experimental vaccine to prevent progression of Type 1 diabetes failed at the second step of the three-phase trial process. It is understood that the vaccine sought to protect insulin-producing...

Insulin Could Be Replaced For Type 1 Diabetes Remedies

Feb. 1 | Medical research striving for an answer to cure Type 1 diabetes could possibly see some light of hope to replace insulin one day if the present study is to be believed and proves to be the path breaking one.  In a study conducted by researchers at UT...